Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Sarepta Therapeutics, Inc. (SRPT) had Current Ratio of 2.32 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$442.93M |
|
$-282.85M |
|
$398.71M |
|
$44.23M |
|
$854.52M |
|
$-411.58M |
|
$133.29M |
|
$-278.30M |
|
$-278.30M |
|
$-282.85M |
|
$-282.85M |
|
$-282.85M |
|
$-282.85M |
|
$-411.58M |
|
$-406.71M |
|
100.12M |
|
100.12M |
|
$-2.74 |
|
$-2.62 |
|
| Balance Sheet Financials | |
$2.54B |
|
$345.12M |
|
$811.76M |
|
$3.35B |
|
$1.10B |
|
$828.97M |
|
$1.11B |
|
$2.21B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
104.96M |
|
| Cash Flow Statement Financials | |
$-205.48M |
|
$69.64M |
|
$-168.34M |
|
$1.12B |
|
$814.41M |
|
$-304.18M |
|
$123.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.32 |
-- |
|
-- |
|
0.42 |
|
0.73 |
|
9.98% |
|
-92.92% |
|
-92.92% |
|
-- |
|
-62.83% |
|
-63.86% |
|
$-307.45M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.44 |
|
1.11 |
|
80.92 |
|
-24.80% |
|
-24.80% |
|
-8.44% |
|
-14.36% |
|
$10.87 |
|
$-3.07 |
|
$-2.05 |
|